全文获取类型
收费全文 | 123591篇 |
免费 | 18316篇 |
国内免费 | 4867篇 |
专业分类
耳鼻咽喉 | 1410篇 |
儿科学 | 2347篇 |
妇产科学 | 1478篇 |
基础医学 | 7668篇 |
口腔科学 | 3675篇 |
临床医学 | 20767篇 |
内科学 | 16335篇 |
皮肤病学 | 2017篇 |
神经病学 | 6659篇 |
特种医学 | 4931篇 |
外科学 | 13389篇 |
综合类 | 21684篇 |
现状与发展 | 15篇 |
一般理论 | 28篇 |
预防医学 | 16181篇 |
眼科学 | 2067篇 |
药学 | 10584篇 |
116篇 | |
中国医学 | 8376篇 |
肿瘤学 | 7047篇 |
出版年
2024年 | 478篇 |
2023年 | 2926篇 |
2022年 | 3077篇 |
2021年 | 4572篇 |
2020年 | 4664篇 |
2019年 | 2538篇 |
2018年 | 4226篇 |
2017年 | 4887篇 |
2016年 | 4365篇 |
2015年 | 6076篇 |
2014年 | 7532篇 |
2013年 | 9094篇 |
2012年 | 9709篇 |
2011年 | 10124篇 |
2010年 | 9450篇 |
2009年 | 9157篇 |
2008年 | 8258篇 |
2007年 | 7907篇 |
2006年 | 7191篇 |
2005年 | 5829篇 |
2004年 | 4468篇 |
2003年 | 3830篇 |
2002年 | 3164篇 |
2001年 | 2282篇 |
2000年 | 1469篇 |
1999年 | 1039篇 |
1998年 | 1030篇 |
1997年 | 989篇 |
1996年 | 999篇 |
1995年 | 793篇 |
1994年 | 652篇 |
1993年 | 567篇 |
1992年 | 381篇 |
1991年 | 334篇 |
1990年 | 260篇 |
1989年 | 308篇 |
1988年 | 264篇 |
1987年 | 231篇 |
1986年 | 218篇 |
1985年 | 190篇 |
1984年 | 161篇 |
1983年 | 151篇 |
1982年 | 136篇 |
1981年 | 122篇 |
1980年 | 96篇 |
1979年 | 47篇 |
1978年 | 53篇 |
1977年 | 61篇 |
1976年 | 55篇 |
1971年 | 34篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
2.
4.
6.
7.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
8.
Kuo-yi Jade Chang MHealthEc MHM BSc Lisa Lorraine Dillon MSpecEd BPsych Lil Deverell COMS PhD MEd GradDipO&M BEd Mei Ying Boon PhD BOptom FAAO Lisa Keay PhD MPH BOptom 《Clinical & experimental optometry》2020,103(4):434-448
Despite orientation and mobility (O&M) being a significant factor determining quality of life of people with low vision or blindness, there are no gold standard measures or agreement on how to measure O&M performance. In the first part of this systematic review, an inventory of O&M outcome measures used by recent studies to assess the performance of orientation and/or mobility of adults with vision impairment (low vision and blindness) is presented. A wide variety of O&M outcome measures have been implemented in different fields of study, such as epidemiologic research and interventional studies evaluating training, assistive technology, vision rehabilitation and vision restoration. The most frequent aspect of outcome measures is efficiency such as time, distance, speed and percentage of preferred walking speed, followed by obstacle contacts and avoidance, and dis/orientation and veering. Other less commonly used aspects are target identification, safety and social interaction and self-reported outcome measures. Some studies employ sophisticated equipment to capture and analyse O&M performance in a laboratory setting, while others carry out their assessment in real-world indoor or outdoor environments. In the second part of this review, the appropriateness of implementing the identified outcome measures to assess O&M performance in clinical and functional O&M practice is evaluated. Nearly a half of these outcome measures meet all four criteria of face validity (either clinical or functional), responsiveness, reliability and feasibility and have the potential to be implemented in clinical or functional O&M practice. The findings of this review confirm the complicated and dynamic nature of O&M. Multiple measures are required in any evaluation of O&M performance to facilitate holistic assessment of O&M abilities and limitations of each individual. 相似文献
9.
目的:观察血府逐瘀汤合温胆汤加减联合西药治疗高血压颈动脉硬化的效果。方法:选取2017年6月至2018年6月聊城市中医院收治的高血压颈动脉硬化患者92例作为研究对象,按照随机数字表法随机分为对照组与观察组,每组46例。对照组患者给予左旋氨氯地平+阿托伐他汀口服,观察组在对照组基础上加用血府逐瘀汤合温胆汤加减口服。观察患者血压、血脂控制情况,测定颈动脉内膜中层厚度(IMT)、斑块面积、血管皮内皮功能、血清蛋白酶分子水平。结果:与对照组比较,观察组治疗后的血压SBP、DBP及血脂TG、TC、LDL-C等指标更低(P<0.05);颈动脉粥样硬化斑块IMT厚度、斑块面积明显缩小(P<0.05),血管内皮功能指标ET-1、AngⅡ、TXB2水平明显降低,NO水平明显升高(P<0.05);血清CatK、MMP-9水平明显降低(P<0.05);观察组不良反应发生率8.70%明显低于对照组不良反应发生率21.74%(P<0.05)。结论:血府逐瘀汤合温胆汤加减联合西药更利于控制高血压颈动脉硬化患者的血压,调节脂质代谢,改善血管内皮功能,降低血清蛋白酶分子的含量,用药安全。 相似文献
10.
目的 观察甘草炮制雷公藤Tripterygium wilfordii后对小鼠血清中代谢产物的影响,初步探讨其降低肝毒性的可能代谢通路。方法 将C57BL/6小鼠随机分为对照(Con)组、雷公藤(Raw)组、甘草炮制雷公藤(Pro)组,观察小鼠肝组织病理变化,检测小鼠肝功能生化指标、炎症因子水平;利用液质联用(LC-MS)技术结合代谢组学方法,对各组间的代谢差异进行表征。结果 与Raw组相比,Pro组小鼠肝组织损伤显著改善,肝功能生化指标、炎症因子水平显著降低,表明甘草炮制雷公藤后可以降低小鼠肝毒性;共筛选出脂肪酸、磷脂酸、甘油酯、磷脂酰胆碱、胆酸等12个潜在生物标志物,主要涉及脂肪酸生物合成、甘油磷脂代谢、花生四烯酸代谢等9个代谢通路。结论 甘草炮制雷公藤可有效降低小鼠的肝毒性,其机制可能与调节脂肪酸代谢等通路相关,为其临床合理应用提供参考依据。 相似文献